跳至主要内容
临床试验/NCT06375629
NCT06375629终止不适用

A Multi-institutional Prospective Data Collection of Patients Treated With Partial Gland High-Intensity Focused Ultrasound (HIFU) Ablation for Prostate Cancer

EDAP TMS S.A.5 个研究点 分布在 1 个国家目标入组 14 人开始时间: 2023年4月20日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
14
试验地点
5
主要终点
Evaluation of urinary incontinence

研究概览

简要总结

The objective of this study is to evaluate the clinical effectiveness and safety of treatment of prostate cancer in patients who have received a focal HIFU treatment using the Focal One medical device.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Patient eligible for HIFU treatment for prostate cancer, excluding whole gland treatment.
  • Patient newly diagnosed with localized prostate cancer confirmed with an image guided biopsy (MRI and/or micro-ultrasounds).
  • Gleason ≤ 4+
  • Patient scheduled for HIFU treatment as determined by the physician.
  • Patient with healthcare coverage. Spanish-speaking patients with the ability to provide informed written consent

排除标准

  • Patient with bilateral prostate cancer requiring whole gland treatment.
  • Patients clinically detected metastasis.
  • Patient with an extension of cancer or seminal vesicle invasion.
  • Patient with contraindications for HIFU treatment: please refer to the complete Focal One user manual.

结局指标

主要结局

Evaluation of urinary incontinence

时间窗: 3, 6, 9 and 12 months

ICIQ questionnaire

Erectile function assessment

时间窗: 3, 6, 9 and 12 months

IIEF-5 questionnaire

Evaluation of adverse events

时间窗: 1 year

using the Clavien-Dindo classification

Evaluation of quality of life

时间窗: 3, 6, 9 and 12 months

IQL questionnaires

Urinary Symptoms

时间窗: 3, 6, 9 and 12 months

IPSS questionnaire

次要结局

未报告次要终点

研究者

发起方
EDAP TMS S.A.
申办方类型
Industry
责任方
Sponsor

研究点 (5)

Loading locations...

相似试验